Federal contractor profile

HBVTECH, L.L.C

UEI WEXNYHY4EZB5CAGE 6WC76

Active

Small Business

Overview

Legal name: HBVTECH, L.L.C
Registered location: GERMANTOWN, MD, USA
Primary NAICS: 541714 — Research and Development in Biotechnology (except Nanobiotechnology)
Latest award activity: Jul 13, 2026

Read company summary

HBVTECH, L.L.C is associated with UEI WEXNYHY4EZB5 and CAGE 6WC76 in public federal records. AcornBids currently links 1 prime award totaling $606.2K in obligations to this entity. Its largest recorded federal customer by obligations is Department of Health and Human Services. Its recorded federal awards include work classified as Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology). These categories describe the loaded award records, not a complete list of company capabilities. Its primary SAM.gov NAICS is 541714 (Research and Development in Biotechnology (except Nanobiotechnology)). Its public SAM.gov registration lists GERMANTOWN, MD, USA.

At a glance

Lifetime prime obligations$606.2K

Prime awards1

Awards with future end dates1

Top-agency concentration100.0%

Prime contract obligations across loaded award records. Obligations are not revenue or contract ceilings. Summary updated Sep 28, 2026. Refresh pending; these totals may be out of date.

Business information

Public SAM.gov registration details.

Legal name: HBVTECH, L.L.C
UEI: WEXNYHY4EZB5
CAGE: 6WC76
Registered address: 13901 LULLABY RD, GERMANTOWN, MD, 20874, USA
Registration status: Active
Primary NAICS: 541714 — Research and Development in Biotechnology (except Nanobiotechnology)
SAM activation: Dec 21, 2025
Initial registration: Apr 26, 2013
Entity start: Apr 23, 2013
SAM updated: Dec 21, 2025
Registration expires: Dec 21, 2026
Fiscal year end: Sep 30
Place of incorporation: MD, USA

View SAM.gov source

Federal award analysis

Net transaction obligations by federal fiscal period.

Transaction history is not available in the loaded data. Annual funding is not estimated from current award totals.

Recent federal awards

Prime contract awards. Select an award to review its history and source evidence.

Award / description	Awarding agency	Obligations	Start date	End date
75N93025C00023EVALUATING HBVZ10-BASED THERAPIED FOR CCCDNA CLEARANCE: VIROLOGICAL FOUNDATION AND SYNERGISTIC COMBINATIONS	Department of Health and Human Services	$606.2K	Aug 1, 2025	Jul 31, 2030

Explore, filter and export all awards →Subcontracts Grants & subgrants

Upcoming positioning windows

Modeled recompete windows are estimates, not announced solicitations or guarantees.

EVALUATING HBVZ10-BASED THERAPIED FOR CCCDNA CLEARANCE: VIROLOGICAL FOUNDATION AND SYNERGISTIC COMBINATIONS

Department of Health and Human Services$606.2K obligationsEnds Jul 31, 203045% recompete estimate

Registration, certifications & contacts

Registration evidence	Date
SAM updated	Dec 21, 2025
Source loaded	Sep 26, 2026
Initial registration	Apr 26, 2013
Entity start	Apr 23, 2013

Registration classifications: Self Certified Small Disadvantaged Business, Small Business. These are separate from the reported certificates above.

Industry	Reported size status
541714 — Research and Development in Biotechnology (except Nanobiotechnology)	Not reported

Contact	Role	Published contact methods	Evidence	Source date
YONG-YUAN ZHANG	Government business	Contact method not published	SAM registration	Not available
YONG-YUAN ZHANG	Electronic business	Contact method not published	SAM registration	Not available

Registered industries

541714 — Research and Development in Biotechnology (except Nanobiotechnology)

Registration classifications and published certificates do not by themselves establish eligibility for a particular solicitation. View SAM source